NN1218

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for NN1218, covering 2013-12-10 to 2017-01-18. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes [Phase 1]